Harvard Apparatus Regenerative Technology, Inc. financial data

Symbol
HRGN on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
84 October Hill Road, Suite 11, Holliston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Biostage, Inc. (to 7/10/2023)
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 133 % -36.9%
Debt-to-equity 75.6 %
Return On Equity -388 % -202%
Return On Assets -222 % -27.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.9M shares +14.3%
Common Stock, Shares, Outstanding 13.9M shares +9.68%
Entity Public Float 33.8M USD -2.03%
Common Stock, Value, Issued 139K USD +9.45%
Weighted Average Number of Shares Outstanding, Basic 13.9M shares +14.3%
Weighted Average Number of Shares Outstanding, Diluted 13.9M shares +14.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Revenue from Contract with Customer, Excluding Assessed Tax 57K USD
Research and Development Expense 3.39M USD +74.2%
Selling and Marketing Expense 115K USD
General and Administrative Expense 1.11M USD -53.3%
Operating Income (Loss) -8.12M USD -18.9%
Nonoperating Income (Expense) 45K USD -43.8%
Net Income (Loss) Attributable to Parent -8.09M USD -19.1%
Earnings Per Share, Basic -0.58 USD/shares +1.7%
Earnings Per Share, Diluted -0.58 USD/shares +1.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 272K USD
Cash, Cash Equivalents, and Short-term Investments 300K USD
Accounts Receivable, after Allowance for Credit Loss, Current 7K USD
Inventory, Net 44K USD
Other Assets, Current 51K USD +325%
Assets, Current 617K USD -83%
Property, Plant and Equipment, Net 19K USD -58.7%
Operating Lease, Right-of-Use Asset 21K USD -82.5%
Other Assets, Noncurrent 62K USD -64.2%
Assets 2.42M USD -44.3%
Accounts Payable, Current 890K USD +17.9%
Employee-related Liabilities, Current 82K USD -1.21%
Liabilities, Current 2.24M USD +68.9%
Operating Lease, Liability, Noncurrent 11K USD +22.2%
Liabilities 968K USD -31.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1K USD
Retained Earnings (Accumulated Deficit) -94M USD -9.41%
Stockholders' Equity Attributable to Parent 175K USD
Liabilities and Equity 2.42M USD -44.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -960K USD +5.23%
Net Cash Provided by (Used in) Financing Activities 801K USD -73.7%
Net Cash Provided by (Used in) Investing Activities -11K USD -120%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 13.9M shares +9.68%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -809K USD -1486%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 432K USD -65.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 14K USD +55.6%
Deferred Tax Assets, Valuation Allowance 23M USD -0.77%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 23M USD -0.88%
Operating Lease, Liability 21K USD -82.5%
Depreciation 6K USD -50%
Payments to Acquire Property, Plant, and Equipment 11K USD +120%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.03M USD +31.6%
Lessee, Operating Lease, Liability, to be Paid 22K USD -83.3%
Property, Plant and Equipment, Gross 1.49M USD +0.75%
Operating Lease, Liability, Current 21K USD -78.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5K USD -90.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 50K USD -56.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -91.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 19.2M USD -6.44%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 27K USD -10%
Additional Paid in Capital 94M USD +11%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 13K USD -67.5%
Share-based Payment Arrangement, Expense 560K USD -69.6%
Interest Expense 14K USD +55.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares